John Bilezikian is an Internal Medicine provider in New York, New York. Dr. Bilezikian is highly rated in 21 conditions, according to our data. His top areas of expertise are Hyperparathyroidism, Hypoparathyroidism, Hypercalcemia, Parathyroidectomy, and Hormone Replacement Therapy (HRT).

Jeffrey Moses is an Internal Medicine provider in New York, New York. Dr. Moses is highly rated in 20 conditions, according to our data. His top areas of expertise are Coronary Heart Disease, Angina, Heart Attack, Percutaneous Coronary Intervention (PCI), and Atherectomy.

Shonni Silverberg is an Internal Medicine provider in New York, New York. Dr. Silverberg is highly rated in 12 conditions, according to our data. Her top areas of expertise are Hyperparathyroidism, Osteoporosis, Postmenopausal Osteoporosis, Hypercalcemia, and Parathyroidectomy.

Saakshi Khattri is an Internal Medicine provider in New York, New York. Dr. Khattri is highly rated in 82 conditions, according to our data. Her top areas of expertise are Psoriasis, Plaque Psoriasis, Psoriatic Arthritis, and Hidradenitis Suppurativa.

Mathew S. Maurer, MD - Dr. Maurer is a general internist and geriatric cardiologist with advanced training in heart failure and cardiac transplantation.  He is the Arnold and Arlene Goldstein Professor of Cardiology at Columbia University Irving Medical Center, Vagelos College of Physicians & Surgeons, where directs the Clinical Cardiovascular Research Laboratory for the Elderly (CCRLE). Dr. Maurer is a member of the Advanced Cardiac Care Center at NewYork Presbyterian Hospital – Columbia Campus.  He is the Director of the Cardiac Amyloidosis Program. He has published over 300 articles including peer reviewed manuscripts, reviews and book chapters. He was Chair of the American College of Cardiology’s Geriatric Cardiology Member Section, which is the largest organization dedicated to advancing the care of older adults with cardiovascular disease. He was co-chair of the Steering Committee of the ATTR-ACT trial showing tafamidis was a safe and effective therapy for transthyretin amyloid cardiomyopathy.   Throughout his career, he has promulgated an approach to older adults with cardiovascular disease that offers the best of both geriatric and cardiovascular medicine in which a comprehensive holistic approach to enhance functional capacity and quality of life is at the forefront of emerging techniques to address cardiovascular physiologic derangement that disproportionately afflict older adults. Dr. Maurer is highly rated in 21 conditions, according to our data. His top areas of expertise are Cardiac Amyloidosis, Primary Amyloidosis, Transthyretin Amyloid Cardiomyopathy, Heart Transplant, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Hershman is Witten Family Professor of Medicine, American Cancer Society Professor of Medicine and Epidemiology, chief of the division of hematology/oncology, and deputy director of the Herbert Irving Comprehensive Cancer Center at Columbia University. She completed her medical degree at the Albert Einstein College of Medicine, and completed her internal medicine and oncology fellowship training at Columbia University Medical Center, where she served as Chief Resident. During that time she completed a Master's degree in Biostatistics at the Mailman School of Public Health. She has developed nationally recognized expertise in breast cancer treatment, prevention, and survivorship.Dr. Hershman has also developed a comprehensive multidisciplinary program to study ways of improving cancer care delivery (CCD), reducing disparities and designing studies to improve the quality of life and quality of care in breast cancer survivors. She has received funding from the American Society of Clinical Oncology, American Cancer Society, Department of Defense, Breast Cancer Research Foundation, PCORI, and the National Cancer Institute. She currently has mentored numerous faculty members who have been granted mentored career development awards, and has received the Women Who Conquer Cancer Mentorship Award and the CUIMC Mentor of the Year Award. Dr. Hershman has published over 450 scientific articles and has received several awards including the highly prestigious Advanced Clinical Research Award in Breast Cancer from the American Society of Clinical Oncology, the Advanced Medical Achievement Award from the Avon Foundation and a Giants in Cancer Care Award.She has several national leadership roles in oncology. As vice chair of the SWOG Cancer Research Network she oversees the NCI's Community Oncology Research Programs (NCORP) research portfolio, which includes prevention and epidemiology, cancer care delivery, symptom control and quality of life, and survivorship trials. Within ASCO she was selected to participate in the first Leadership Development Program and has been the Chair of the Grants Selection Committee, Chair of the ASCO Quality Care Symposium and has been a member of multiple committees and task-forces. She is on the editorial board for the Journal of Clinical Oncology and is an Associate Editor at the Journal of the National Cancer Institute. Dr. Hershman is highly rated in 19 conditions, according to our data. Her top areas of expertise are Breast Cancer, Febrile Neutropenia, Inflammatory Breast Cancer, Vulvectomy, and Salpingo-Oophorectomy.

Myron M. Studner Professor of Cancer Research and Professor of Medicine and Epidemiology at Columbia University, Associate Director for Population Science, Leader of the Prevention, Control, and Disparities Program for the Herbert Irving Comprehensive Cancer Center at Columbia, and Co-Director of the Cancer Prevention Center of New York Presbyterian Hospital Dr. Neugut is a medical oncologist with a particular interest in gastroIntestinal tract cancers, especially of colorectal and gasteric cancers. Under the auspices of Columbia's MD/PhD program, he received his MD and a PhD in Pathobiology in 1977. He did his training in Internal Medicine at the Albert Einstein College of Medicine and fellowship in Medical Oncology at Memorial Sloan-Kettering Cancer Center. He returned to Columbia University as an Andrew Mellon Fellow in Epidemiology and Medicine to obtain an MPH in Epidemiology in 1983. Dr. Neugut then joined the faculty at Columbia University with appointments in Medicine and Epidemiology.As both a practicing medical oncologist and cancer epidemiologist, Dr. Alfred Neugut's major interests have been on GI tract cancers, notably the epidemiology of colorectal adenomas and cancer, as well as colonoscopic screening. He serves as co-principal investigator of the Long Island Breast Cancer Study Project, a large multi-center effort to explore environmental causes of breast cancer on Long Island. Most recently, his efforts have focused on more clinical topics, such as the epidemiology of second malignancies and the use of chemotherapy and radiation therapy among elderly cancer patients. Dr. Neugut focuses a great deal on racial disparities in incidence and survival from cancer and, in particular, variations across subgroups of people of African descent. He leads two large training grants in cancer-related population sciences that together fund 15 pre and postdoctoral trainees in cancer epidemiology, biostatistics, and environmental health sciences, and serves as a mentor to a number of junior faculty. Dr. Neugut is highly rated in 16 conditions, according to our data. His top areas of expertise are Colorectal Cancer, Breast Cancer, Familial Colorectal Cancer, Endoscopy, and Colonoscopy.

Jennifer Amengual is an Internal Medicine specialist and an Oncologist in New York, New York. Dr. Amengual is highly rated in 14 conditions, according to our data. Her top areas of expertise are Non-Hodgkin Lymphoma, T-Cell Lymphoma, Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Bone Marrow Aspiration. Dr. Amengual is currently accepting new patients.

Gulam Manji, M.D., Ph.D. is an Associate Professor of Medicine at Columbia University Medical Center. Dr. Manji received his M.D. degree from Ross University School of Medicine in 2009 and completed his residency in internal medicine at Albany Medical College. He then completed his fellowship in Hematology/Oncology at NewYork-Presbyterian/Columbia, where his clinical focus was on the treatment of gastrointestinal malignancies, melanoma, and sarcoma under the mentorship of Dr. Gary Schwartz, Chief of Hematology and Oncology.Dr. Manji conducts translational research with the overall goal to developing new treatments for cancer. His focus is in gastrointestinal malignancies, particularly pancreas adenocarcinoma, on which he is conducting preclinical combination immunotherapy studies on genetically engineered mice with pancreas cancer in the Olive laboratory at the Herbert Irving Comprehensive Cancer Center. The combination immunotherapy preclinical proposal received the Young Investigator Award from the American Society of Clinical Oncology-2015. The goal of these preclinical studies is to bring promising new therapies to the clinic in an early phase clinical trials Dr. Manji's research career in identifying new genes and their implication in disease has led to numerous key publications and an issued patent.Dr. Manji cares for patients with gastrointestinal malignancies, with a particular focus on pancreatic and liver cancers, and sarcomas. He is the principal investigator of an investigator-initiated multicenter clinical trial that he wrote with Dr. Gary Schwartz in sarcoma and malignant peripheral nerve sheath tumors and is responsible for clinical trials conducted in liver, bile duct, gallbladder, and pancreas cancers at Columbia University Medical Center. Dr. Manji is highly rated in 14 conditions, according to our data. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Malignant Peripheral Nerve Sheath Tumor, and Familial Pancreatic Cancer.

Charles Drake is an Internal Medicine provider in New York, New York. Dr. Drake is highly rated in 14 conditions, according to our data. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Bladder Cancer, Nephrectomy, and Prostatectomy.

Dr. Catherine Shu is the Price Family Associate Professor of Medicine and a board-certified medical oncologist specializing in the treatment of thoracic cancers, with a focus on lung cancer. She received her undergraduate degree from Princeton University, followed by her M.D. from Columbia University College of Physicians and Surgeons. After residency at Columbia University Medical Center, Dr. Shu completed her fellowship at Memorial Sloan Kettering Cancer Center, where she was appointed Chief Fellow. She currently serves as the Director of the Thoracic Medical Oncology Service. She has presented her work at numerous international conferences and has published in the top peer-reviewed oncology journals. She treats the entire spectrum of lung cancer, and has a particular interest in earlier stage and surgically resectable disease, specifically on drug combinations to help improve survival in this setting. Additionally, she runs the thoracic oncology clinical trial portfolio and devotes part of her research effort to patients with targetable mutations such as EGFR. Of all her achievements, she is proudest to be able to offer individualized and compassionate care to each and every one of her patients. She understands that each patient and family carries forth a different set of beliefs, goals, and needs. Working alongside an exceptional multidisciplinary team, she is dedicated to improving the survival and bettering the quality of life of her patients. Dr. Shu is highly rated in 13 conditions, according to our data. Her top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), and Salpingo-Oophorectomy.

Susan Bates is an Internal Medicine specialist and an Oncologist in New York, New York. Dr. Bates is highly rated in 11 conditions, according to our data. Her top areas of expertise are Pancreatic Cancer, T-Cell Lymphoma, Pancreatic Ductal Adenocarcinoma, and Cutaneous T-Cell Lymphoma (CTCL). Dr. Bates is currently accepting new patients.

Melana Yuzefpolskaya, MD is a cardiologist, specializing in the diagnosis and treatment of patients with advanced heart failure, with a special interest in mechanical circulatory support (MCS) with left ventricular assist devices (LVADs) and heart transplantation.  She is board certified in General Cardiology, Echocardiography, Nuclear Cardiology and Advanced Heart Failure and Cardiac Transplantation.Dr. Yuzefpolskaya is an Associate Professor of Medicine in the Division of Cardiology. She received her medical degree from New York University School of Medicine, completed her Residency in Internal Medicine at NYU, Fellowship in Cardiovascular Diseases at St. Luke's Roosevelt Medical Center and advanced training in advanced heart failure, cardiac assist devices and transplantation at Columbia University Medical Center in New York.Dr. Yuzefpolskaya has co-authored more than 145 peer-reviewed manuscripts in prestigious journals, including Journal of Heart and Lung Transplantation, Circulation: Heart Failure, European Journal of Heart Failure, Journal of Cardiac Failure and the Journal of the American College of Cardiology. Her work has been presented at multiple national and international meetings including American Heart Association, Heart Failure Society of America, International Society of Heart and Lung Transplantation, and European Mechanical Circulatory Support Summit. She serves as an ad hoc reviewer on multiple journals and has contributed to guidelines on treatment and management of patients with cardiac assist devices.Dr. Yuzefpolskaya joined the Faculty at the Center for Advanced Cardiac Care in 2011, and was named the Associate Medical Director of the Mechanical Circulatory Support/LVAD Program at New York-Presbyterian/Columbia University Medical Center in 2014. She sees patients in Washington Heights in New York City. Dr. Yuzefpolskaya is highly rated in 11 conditions, according to our data. Her top areas of expertise are Heart Failure, Cardiogenic Shock, Heart Attack, Heart Transplant, and Heart Valve Repair.

Matthew Lewis MD MPH is a cardiologist who specializes in general cardiology and adult congenital heart disease. He has a clinical interest in complex congenital heart disease and is a co-director of the Adult Single Ventricle Clinic at Columbia University Medical Center and serves as the director of the Adult Congenital Heart Disease Research Program. Dr. Lewis is board certified in Cardiovascular Medicine and Adult Congenital Heart Disease.Dr. Lewis completed his MD and Masters in Public Health from Harvard Medical School. Following, he completed the Harvard combined Internal Medicine and Pediatrics Residency at Brigham and Women’s Hospital and Boston Children’s Hospital where he served as Chief Resident. After residency, Dr. Lewis completed fellowship training at NewYork-Presbyterian Hospital/Columbia University Medical Center where he also served as Chief Fellow prior to completing an Adult Congenital Heart Disease Fellowship.Dr. Lewis has experience with patient care, teaching and research and has received grant funding from the National Institute of Health and Adult Congenital Heart Association as a primary investigator and from the Department of Defense as a co-investigator. He has published extensively in the field of Congenital Heart Disease and has particular research focus on utilizing translational research and genomics to improve the outcomes of patients with single ventricle physiology.Dr. Lewis sees patients at Columbia University Medical Center in Washington Heights, NY. Dr. Lewis is highly rated in 10 conditions, according to our data. His top areas of expertise are Congenital Heart Disease (CHD), Tetralogy of Fallot, Subvalvular Aortic Stenosis, Cor Triatriatum, and Heart Transplant.

Dr. Ersilia M. DeFilippis, FACC, FAHA, FHFSA is a highly accomplished physician and an Assistant Professor of Cardiology and Advanced Heart Failure and Transplant Cardiologist at Columbia University Irving Medical Center. She graduated from Yale University summa cum laude with a Bachelors of Arts in Women’s Studies and a concentration in Women’s Health. Dr. DeFilippis received her medical degree from Weill Cornell Medical College where she was inducted into the Alpha Omega Alpha honor Society and graduated with an MD with Honors in Research. She was also granted the Janet M. Glasgow-Rubin Memorial Achievement Award for graduating first in her medical school class. She then completed her Internal Medicine residency at Brigham and Women’s Hospital in Boston. Subsequently, she finished her fellowships in cardiovascular disease and advanced heart failure and transplant cardiology at Columbia University Irving Medical Center. She is board certified in internal medicine, cardiology, and advanced heart failure and transplant cardiology. Her clinical interests include peripartum cardiomyopathy, pregnancy and cardiovascular disease, heart failure, heart transplantation, and mechanical circulatory support. Her research interests include sex-specific outcomes and disparities in advanced heart failure and transplantation as well as the intersection of heart failure and cardio-obstetrics. She is also interested in health disparities and health equity more broadly.She has over 230 peer-reviewed publications and has published in leading journals including JAMA Cardiology, Journal of Heart and Lung Transplantation, Circulation: Heart Failure; JACC and JACC: Heart Failure. She has also given invited talks at multiple national and international conferences. She received the 2024 American Society of Transplantation Clinical Career Development Achievement Award for her research endeavors and was named a 2025 Lewis Katz Scholar by the Division of Cardiology. She was a Co-Chair of the ISHLT Consensus Statement on Reproductive Health after Thoracic Transplantation and has served as a member of various committees for the American College of Cardiology, Heart Failure Society of America, American Heart Association, and American Society of Transplantation. She is also a member of the Executive Committee of the Women’s Health Community of Practice of the American Society of Transplantation and the Diverse Populations Editor for the Journal of Cardiac Failure. She is a fellow of the American College of Cardiology, Heart Failure Society of America, and American Heart Association. Dr. Defilippis is highly rated in 10 conditions, according to our data. Her top areas of expertise are Heart Failure, Peripartum Cardiomyopathy, SVC Obstruction, Heart Transplant, and Pacemaker Implantation.

Shunichi Homma is an Internal Medicine provider in New York,, New York. Dr. Homma is highly rated in 9 conditions, according to our data. His top areas of expertise are Patent Foramen Ovale, Atrial Septal Defect (ASD), Emery-Dreifuss Muscular Dystrophy, Parathyroidectomy, and Patent Foramen Ovale Repair.

Dr. Bernstein's clinical and research interests focus on systemic sclerosis (scleroderma), as well as on the detection and treatment of interstitial lung disease and pulmonary hypertension in patients with autoimmune diseases. She is the Florence Irving Associate Professor of Medicine at Columbia University Vagelos College of Physicians and Surgeons and an Associate Attending at NewYork-Presbyterian Hospital. Dr. Bernstein is the founder and Director of the Columbia University/NewYork-Presbyterian Scleroderma Center.Dr. Bernstein graduated summa cum laude from Amherst College, and was inducted into the Alpha Omega Alpha medical honor society while a medical student at the Mount Sinai School of Medicine. She was the recipient of the American College of Rheumatology Distinguished Fellow Award and the Charles L. Christian Award for Excellence in Musculoskeletal Research while a rheumatology fellow at Hospital for Special Surgery. In recognition of her outstanding contributions to systemic sclerosis research, Dr. Bernstein received the Edith Busch Prize for Young Investigators at the 8th Systemic Sclerosis World Congress. Dr. Bernstein has received grants from the National Institutes of Health, Department of Defense, Arthritis Foundation, and Rheumatology Research Foundation to study lung disease in scleroderma. Her ongoing research projects focus on interstitial lung disease in scleroderma and on lung transplantation in patients with autoimmune diseases. Dr. Bernstein is highly rated in 8 conditions, according to our data. Her top areas of expertise are Systemic Sclerosis (SSc), Scleroderma, Scleredema, and Scleroma.

Katherine D. Crew, M.D., M.S. is an the Avon Products Foundation Professor of Medicine and Epidemiology at the NewYork-Presbyterian/Columbia University Medical Center, co-associate director for education and training and co-director of the Cancer Research Training and Education Core (CRTEC) at the Herbert Irving Comprehensive Cancer Center (HICCC). In addition to treating patients with breast cancer and women at high-risk for breast cancer, Dr. Crew has a long-standing interest and background in the design of clinical trials and observational studies in breast cancer prevention and survivorship.She serves as the Director of the Clinical Breast Cancer Prevention Program at Columbia University and Executive Officer for the SWOG Prevention, Screening, and Surveillance and Cancer Care Delivery Committees. She is a member of multiple national consortia and societies in oncology, including the American Association for Cancer Research and American Society of Clinical Oncology, and is an editorial board member of the Journal of Clinical Oncology. Dr. Crew received her undergraduate B.S. in Biochemistry from Brown University, where she graduated Magna Cum Laude. She received her M.D. from Columbia University College of Physicians and Surgeons and her M.S. from Columbia University School of Public Health. She completed her Internal Medicine residency and Medical Oncology fellowship at NewYork-Presbyterian/Columbia University Medical Center. Dr. Crew is highly rated in 8 conditions, according to our data. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Salpingo-Oophorectomy.

Dr. Kevin Clerkin is an Assistant Professor of Medicine and cardiologist, specializing in the diagnosis and treatment of patients with advanced heart failure. His practice includes those requiring left ventricular assist device or heart transplantation. He also attends as a cardiac intensivist. He is board certified in Internal Medicine, Cardiovascular Disease, Echocardiography, and Advanced Heart Failure & Transplant Cardiology. Dr. Clerkin received his medical degree from Albert Einstein College of Medicine where he was inducted into the Alpha Omega Alpha Honor Society. He completed his internship and residency in Internal Medicine at NewYork-Presbyterian/Columbia University Irving Medical Center. He completed additional training in Cardiovascular Disease and Advanced Heart Failure & Transplant Cardiology at NewYork-Presbyterian/Columbia University Irving Medical Center. He also received a Master of Science degree in Patient Oriented Research/Biostatistics from the Columbia University Mailman School of Public Health.Dr. Clerkin is an NIH funded clinical investigator and his research focuses on improving the quality of life and survival in heart transplant recipients. He has published more than 100 peer reviewed manuscripts, reviews, abstracts, and book chapters. His work has been published in prestigious peer-reviewed journals including Circulation, Journal of American College of Cardiology, Journal of American College of Cardiology Heart Failure, Circulation - Heart Failure, JAMA Cardiology, The New England Journal of Medicine, and The Journal of Heart and Lung Transplantation. Dr. Clerkin is highly rated in 6 conditions, according to our data. His top areas of expertise are Heart Failure, Cardiogenic Shock, COVID-19, Cardiac Amyloidosis, and Heart Transplant.

Ian Kronish, MD, MPH, is a general internist and Florence Irving Associate Professor of Medicine. After attending Harvard Medical School, Dr. Kronish completed his residency and fellowship in internal medicine at Mount Sinai Medical Center, where he also completed a Master’s in Public Health at the Mount Sinai School of Medicine. In 2011, he moved to CUMC, where his clinical practice is in the Associates of Internal Medicine. He is Associate Director of the Center for Behavioral Cardiovascular Health and Co-Director of the Hypertension Center at CUIMC.Dr. Kronish’s research has shown why those at greatest risk for recurrent cardiovascular events are least likely to adhere to prescribed regimens, and that patients’ distress about past and future cardiovascular events undermines health behaviors. As Director of an NIA-funded Roybal Center, he now aims to foster the development of interventions that improve mental health, adherence to recommended health behaviors, and cardiovascular outcomes in patients that have experienced acute cardiovascular events such as acute coronary syndrome and stroke. He has expertise in medication adherence, and has advanced methodologies for adherence measurement. He has been the PI of multiple federally-funded randomized clinical trials. He also has experience in implementation science research, and applies these methods to increase the uptake of evidence-based hypertension guidelines. He is a founding member of New York Presbyterian Hospital’s Digital Health Evaluation initiative, and has led the implementation of remote monitoring programs for hypertension and COVID-19. Dr. Kronish is highly rated in 6 conditions, according to our data. His top areas of expertise are Acute Coronary Syndrome, Post-Traumatic Stress Disorder (PTSD), Hypertension, and Transient Ischemic Attack (TIA).

Dr. Raza is a Professor of Medicine and Director of the MDS Center at Columbia University in New York, NY. She started her research in Myelodysplastic Syndromes (MDS) in 1982 and moved to Rush University, Chicago, Illinois in 1992, where she was the Charles Arthur Weaver Professor in Oncology and Director, Division of Myeloid Diseases. The MDS Program, along with a Tissue Repository containing more than 50,000 samples from MDS and acute leukemia patients was successfully relocated to the University of Massachusetts in 2004 and to Columbia University in 2010.Before moving to New York, Dr. Raza was the Chief of Hematology Oncology and the Gladys Smith Martin Professor of Oncology at the University of Massachusetts in Worcester. She has published the results of her laboratory research and clinical trials in prestigious, peer-reviewed journals such as The New England Journal of Medicine, Nature, Blood, Cancer, Cancer Research, the British Journal of Hematology, Leukemia, and Leukemia Research. Dr. Raza serves on numerous national and international panels as a reviewer, consultant, and advisor and is the recipient of a number of awards. Dr. Raza is highly rated in 4 conditions, according to our data. Her top areas of expertise are Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, and Leukemia.

Elizabeth Shane is an Internal Medicine provider in New York, New York. Dr. Shane is highly rated in 4 conditions, according to our data. Her top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Menopause, and Hyperparathyroidism.

Ethel Siris is an Internal Medicine provider in New York, New York. Dr. Siris is highly rated in 3 conditions, according to our data. Her top areas of expertise are Postmenopausal Osteoporosis, Osteoporosis, Paget's Disease of Bone, Melorheostosis, and Hormone Replacement Therapy (HRT).

Dr. Akiyama is an Associate Professor of Medicine and Clinician-Investigator in the Divisions of General Internal Medicine and Infectious Diseases. In addition to providing care and treatment to people living with HIV, hepatitis C virus (HCV), and substance use disorders, Dr. Akiyama conducts research focusing on HCV among socioeconomically marginalized populations with particular emphasis on the intersection of HCV in the criminal legal system and sub-Saharan Africa. Dr. Akiyama is the recipient of a K99/R00 award from the National Institute on Drug Abuse to develop and test an innovative strategy to improve linkage to and retention in HCV treatment among individuals recently released from jail. He is also the recipient of an Avenir Award from the National Institute on Drug Abuse focused on HCV Transmission Networks Among People Who Inject Drugs. Dr. Akiyama is highly rated in 3 conditions, according to our data. His top areas of expertise are Hepatitis C, Hepatitis, HIV/AIDS, and Severe Acute Respiratory Syndrome (SARS).

Viraj Patel is a primary care provider, practicing in Internal Medicine in Bronx, New York. Dr. Patel is highly rated in 2 conditions, according to our data. His top areas of expertise are HIV/AIDS, Anosmia, COVID-19, and Severe Acute Respiratory Syndrome (SARS).